At Dyne Therapeutics, a filing with the SEC revealed that on Wednesday, CEO & President John Cox purchased 32,000 shares of DYN, for a cost of $33.04 each, for a total investment of $1.06M. Cox was up about 6.2% on the buy at the high point of today's trading session, with DYN trading as high as $35.10 in trading on Thursday. Dyne Therapeutics is trading down about 1.3% on the day Thursday.
And at Citi Trends, there was insider buying on Wednesday, by CFO Heather L. Plutino who purchased 3,573 shares at a cost of $13.99 each, for a total investment of $49,986. This purchase marks the first one filed by Plutino in the past year. Citi Trends is trading up about 1.6% on the day Thursday.
VIDEO: Thursday 9/5 Insider Buying Report: DYN, CTRN
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
